Log In
BCIQ
Print this Print this
 

Oral Ex-RAD, recilisib sodium (ON 01210.Na)

  Manage Alerts
Collapse Summary General Information
Company Onconova Therapeutics Inc.
DescriptionSynthetic, low molecular weight radioprotectant that modulates DNA repair pathways
Molecular Target DNA
Mechanism of ActionRadioprotectant
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPoisoning
Indication DetailsTreat and prevent acute radiation syndrome (ARS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today